Brain volume loss linked to Alzheimer’s treatment may be caused by amyloid plaque removal

A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by UCL researchers.

Why heart device makers are investing in left atrial appendage closure

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. New technologies designed to prevent stroke by

December 12, 2023

Opinion | Ask Your Patients: ‘Have You Gotten Your Annual COVID Shot?’

Ward is an assistant professor of clinical research and leadership. It was nothing short of miraculous that America’s health and public health communities mobilized so

November 29, 2023

Extreme Temps and Particulate Matter in Fatal Heart Attacks; Impact of Thymectomy

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

August 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.